Physician profile
James Duc
NPI 1366449522
$4,746.87
in general payments reported to CMS, 2019-2025
20 companies · $460 in 2025
The $460 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $47.38 · 2022: $36.48 · 2023: $477 · 2024: $2,771 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,934 · Food and Beverage: $1,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,933.52 |
| Food and Beverage | $1,774.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,670.47 | 2023-2025 | Evera Mri Xt Dr Surescan, Linq II, Selectsecure |
| Medtronic Vascular, INC. | $466.88 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $277.20 | 2019 | |
| Boston Scientific Corporation | $238.69 | 2019-2025 | Watchman Access System, Vigilant X4 Crt-D |
| Abbott Laboratories | $164.89 | 2023 | Ensite, Assurity |
| Novartis Pharmaceuticals Corporation | $161.53 | 2022-2025 | |
| Novo Nordisk INC | $147.17 | 2023-2024 | Ozempic, Rybelsus |
| Kestra Medical Technology Services, INC. | $101.90 | 2023-2025 | Assure Wcd |
| Philips North America LLC | $101.56 | 2025 | Ecc Solutions |
| Cvrx, INC. | $97.32 | 2024 | Barostim Neo System |
| Abiomed | $80.63 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $48.99 | 2024-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $35.79 | 2019 | |
| Amarin Pharma, INC. | $30.89 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.00 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $24.60 | 2024 | Recorlev |
| Kiniksa Pharmaceuticals, LTD. | $22.85 | 2023 | Arcalyst |
| Amgen INC. | $18.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.89 | 2024 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $12.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Duc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.